25 Leading India Pharmas Spend Less Than Half Global Average On R&D
This article was originally published in PharmAsia News
Executive Summary
India drug makers still trail the global average in spending on research and development as a percentage of total sales and even then record a low success rate in innovation attempts.
India drug makers still trail the global average in spending on research and development as a percentage of total sales and even then record a low success rate in innovation attempts. Government estimates say India's 25 leading pharmaceutical companies spend about 7% of their sales on R&D, only half of the 12% to 15% world average, equal to 1% of $130 billion global spending. India drug makers tend to spend much of their R&D funds on foreign litigation involving their generics. (Click here for more
)
"Indian Pharma's R&D Magic Pill Turns Out To Be A Placebo" - Financial Express (India) (5/6/2013)